

Fed in Holding Pattern on Interest Rates, December Cut Possible
Apr 30, 2024
Guests discuss Fed's rate decisions, Lilly's drug performance, AI advancements, and city sustainability. They touch on data centers, GenAI, and the challenges faced by pharmaceutical companies regarding drug pricing. Insights on building resilient communities, promoting growth, earnings reports, and market trends. Overall, a diverse range of topics covered with industry experts and insightful discussions.
Chapters
Transcript
Episode notes
1 2 3 4 5 6 7 8 9 10 11
Introduction
00:00 • 2min
Federal Reserve's Dilemma on Interest Rates
01:46 • 8min
Economic Productivity, AI Enhancements, and Stock Performances
09:49 • 2min
Analyzing Eli Lilly's Performance and Market Competition
11:45 • 7min
Challenges Faced by Pharmaceutical Companies Regarding Drug Pricing
18:30 • 2min
AI Innovation and Landscape Evolution
20:29 • 10min
Ethical AI Governance and City Sustainability
30:07 • 3min
Building Resilient Communities and Addressing Crime Epidemic
33:26 • 7min
Discussion on Promoting Growth and Sponsor Mentions by EY and Stiefel
40:34 • 2min
Earnings Reports and Market Trends
42:34 • 7min
Economic Analysis and AI Future Insights
50:01 • 2min